@article{d67265fbb34149279fdc994f874a848e,
title = "Integrating nanomedicine into clinical radiotherapy regimens",
abstract = "While the advancement of clinical radiotherapy was driven by technological innovations throughout the 20th century, continued improvement relies on rational combination therapies derived from biological insights. In this review, we highlight the importance of combination radiotherapy in the era of precision medicine. Specifically, we survey and summarize the areas of research where improved understanding in cancer biology will propel the field of radiotherapy forward by allowing integration of novel nanotechnology-based treatments.",
keywords = "Cancer, Chemoradiotherapy, Dosing, Drug delivery, Multimodal therapy, Nanoparticles, Radiation therapy",
author = "DuRoss, {Allison N.} and Neufeld, {Megan J.} and Shushan Rana and Thomas, {Charles R.} and Conroy Sun",
note = "Funding Information: The authors thank Micheal R. Thompson for his help making several of the figures in this work. This work was supported by the NIH NIGMS Maximizing Investigators' Research Award, 1R35GM119839-01 (C.S.) and Oregon State University College of Pharmacy Startup Funds. Funding Information: The authors thank Micheal R. Thompson for his help making several of the figures in this work. This work was supported by the NIH NIGMS Maximizing Investigators' Research Award, 1R35GM119839-01 (C.S.) and Oregon State University College of Pharmacy Startup Funds. Publisher Copyright: {\textcopyright} 2019 Elsevier B.V.",
year = "2019",
month = apr,
doi = "10.1016/j.addr.2019.07.002",
language = "English (US)",
volume = "144",
pages = "35--56",
journal = "Advanced Drug Delivery Reviews",
issn = "0169-409X",
publisher = "Elsevier",
}